| Date | Title | Description |
| 14.05.2024 | FMC Corporation and Optibrium collaboration aims to accelerate the discovery of novel crop protection technologies by leveraging the power of machine learning and artificial intelligence | PHILADELPHIA, May 14, 2024 /PRNewswire/ --
FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced a collaboration with Optibrium, a leading developer of software and artificial intelligence (AI) solutio... |
| 27.02.2024 | Optibrium launches a metabolism prediction software platform tailored to DMPK scientists | Semeta™ offers high sensitivity and superior precision for the prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discovery
CAMBRIDGE, UK, 27 February 2024 – Optibrium, a leading developer of softwa... |
| 21.06.2022 | Optibrium receives further investment from Kester Capital | Cambridge UK - Optibrium™, a developer of software for drug discovery, announces it has secured further investment from existing investors Kester Capital, a leading UK mid-market private equity firm.
Second round of funding from existing in... |
| 08.06.2022 | Optibrium expands UK head office with new facilities on Cambridge Innovation Park | Optibrium™, a developer of software for drug discovery, announces the expansion of its UK headquarters with a move to larger office premises on Cambridge Innovation Park North. The new facilities accommodate Optibrium's accelerated growth a... |
| 24.09.2021 | With Maverick now in Takeda's hands, James Scibetta turns the page; Roivant CMO leaves in favor of small IL-2 biotech | James Scibetta
→ Another CEO opportunity has presented itself for James Scibetta, the chief executive of Maverick Therapeutics when Takeda ponied up $525 million in March to buy its T cell collaborator and integ... |
| 10.09.2021 | Optibrium releases 3D ligand-based design module for StarDrop drug discovery software | Optibrium releases 3D ligand-based design module for StarDrop drug discovery software
10-09-2021
Optibrium Ltd, a developer of software for drug discovery, has announced the release of the latest version of StarDrop™, its comprehensive soft... |
| 29.06.2021 | Optibrium publishes major peer-reviewed study on AI applications to global pharma data | Optibrium publishes major peer-reviewed study on AI applications to global pharma data
29-06-2021
Published in AI Letters, study collaborators Optibrium, Takeda and Intellegens demonstrated the application of deep learning imputation to a g... |
| 20.05.2021 | Optibrium and BioPharmics enter partnership on computational drug design | Optibrium and BioPharmics enter partnership on computational drug design
20-05-2021
Industry-leading 3D ligand-based design approaches from BioPharmics will be available in StarDrop, Optibrium’s small molecule design and optimisation softwa... |
| 10.02.2021 | Optibrium raises investment to advance computer-aided drug discovery | Optibrium raises investment to advance computer-aided drug discovery
10-02-2021
Investment by Kester Capital will drive commercial growth and the development of new products to improve speed, efficiency, and productivity of the discovery pr... |
| 10.02.2021 | Optibrium raises investment to advance computer-aided drug discovery | Investment by Kester Capital will drive commercial growth and the development of new products to improve speed, efficiency, and productivity of the discovery process.
Optibrium™, a developer of software for drug discovery, today announced i... |
| 20.01.2021 | Optibrium enhances compound design strategies in major upgrade to StarDrop software | Optibrium enhances compound design strategies in major upgrade to StarDrop software
20-01-2021
Optibrium™, a developer of software for drug discovery, has announced the release of the newest version of StarDrop™, a comprehensive software pl... |
| 01.04.2020 | Intellegens and Optibrium achieve further success in Open Source Malaria initiative | Intellegens and Optibrium achieve further success in Open Source Malaria initiative
01-04-2020
Intellegens, AI company with unique deep learning toolset for sparse data, and Optibrium™, leading providers of software and services for drug di... |
| 04.12.2019 | Intellegens and Optibrium celebrate success in global challenge to find novel antimalarial compounds | Intellegens and Optibrium celebrate success in global challenge to find novel antimalarial compounds
04-12-2019
Intellegens, an artificial intelligence (AI) start-up, and, Optibrium™, leading providers of software and services for drug disc... |
| 20.09.2018 | Novel deep learning drug discovery platform gets £1 million innovation boost | Novel deep learning drug discovery platform gets £1 million innovation boost
20-09-2018
Funding to support Artificial Intelligence (AI) in drug discovery takes a significant step forward today as Optibrium, Intellegens, and Medicines Discov... |
| 20.09.2018 | Novel deep learning drug discovery platform gets £1 million innovation boost | Funding to support Artificial Intelligence (AI) in drug discovery takes a significant step forward today as Optibrium, Intellegens, and Medicines Discovery Catapult secure a grant from Innovate UK to fund a £1 million project.
The programme... |
| 01.03.2018 | Cambridge Innovation Park welcomes new tenants | Cambridge Innovation Park welcomes new tenants
01-03-2018
Cambridge Innovation Park is delighted to announce the arrival of Optibrium within its serviced office space in Blenheim House.
Optibrium is a developer of software for small molecul... |
| 06.02.2014 | Cresset announces International Symposium on Compound Design Technologies | Cresset announces International Symposium on Compound Design Technologies
06-02-2014
Innovative providers of computational chemistry software and services, including Cambridge-based Cresset, announce the ‘International Symposium on Compound... |
| 06.02.2014 | Cresset announces International Symposium on Compound Design Technologies | Innovative providers of computational chemistry software and services, including Cambridge-based Cresset, announce the ‘International Symposium on Compound Design Technologies’ in Japan next month.
Cambridge, UK – 6th February 2014 – Cresse... |
| 12.01.2012 | Optibrium expands StarDrop availability with Apple Mac compatibility | Optibrium expands StarDrop availability with Apple Mac compatibility
12-01-2012
CAMBRIDGE, UK, October 18, 2011 – Optibrium launches StarDrop 5.1, an upgraded version of its software platform that helps scientists to guide the design and se... |
| 12.01.2012 | Optibrium expands StarDrop availability with Apple Mac compatibility | CAMBRIDGE, UK, October 18, 2011 – Optibrium launches StarDrop 5.1, an upgraded version of its software platform that helps scientists to guide the design and selection of high quality, novel compounds in drug discovery. As a result of this ... |
| 12.07.2010 | Scientists’ instincts often impaired by biases when making drug discovery decisions, says... | Scientists’ instincts often impaired by biases when making drug discovery decisions, says...
12-07-2010
Optibrium, a provider of software solutions for drug discovery, and Tessella, the information technology and consulting services company... |
| 09.07.2010 | Optibrium secures 25 accounts in first year of business | Optibrium secures 25 accounts in first year of business
09-07-2010
Optibrium, a provider of software solutions for drug discovery, celebrates two significant milestones: its first year of trading and signing its 25th customer.
Based in Camb... |
| 15.02.2010 | Optibrium unveils StarDrop 4.3 | Optibrium unveils StarDrop 4.3
15-02-2010
StarDrop version 4.3 is the first major update of StarDrop from Optibrium. This intuitive software for drug discovery offers advantages over traditional predictive modelling platforms as it specific... |
| 20.11.2009 | Optibrium launches online community for drug optimisation | Optibrium launches online community for drug optimisation
20-11-2009
Optibrium launches its online community, optibrium.com/community, providing a rich environment for users of its StarDrop drug discovery software to interact and gain even ... |
| 16.09.2009 | Optibrium and Molecular Networks collaborate to share complementary technology platforms | Optibrium and Molecular Networks collaborate to share complementary technology platforms
16-09-2009
Optibrium Ltd. and Molecular Networks GmbH today announce plans to further intensify their collaboration and share complementary technology ... |
